Downstaging of a rectal gastrointestinal stromal tumor by neoadjuvant imatinib therapy allowing for a conservative surgical approach.
Santos Fernandes
Gustavo dos
Gd
Castro Cotti
Guilherme Cutait de
GC
Freitas
Daniela
D
Cutait
Raul
R
Hoff
Paulo M
PM
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate
J Clin Oncol. 2006 Oct 10;24(29):4764-74
16954519
Int J Surg Pathol. 2002 Apr;10(2):81-9
12075401
Int J Clin Oncol. 2007 Jun;12(3):212-7
17566845
J Surg Oncol. 2006 Mar 15;93(4):304-11
16496358
Gastric Cancer. 2007;10(3):145-52
17922091
J Clin Oncol. 2006 May 20;24(15):2325-31
16710031
J Clin Oncol. 2008 Feb 1;26(4):626-32
18235122
Lancet. 2001 Oct 27;358(9291):1421-3
11705489
J Surg Oncol. 2009 Jan 1;99(1):42-7
18942073
Ann Surg Oncol. 2007 Apr;14(4):1247-8
17265116
Ann Surg. 2007 Mar;245(3):347-52
17435539
Ann Surg. 2000 Jan;231(1):51-8
10636102